GNRH1 and polycystic ovary syndrome: Recent studies in China found that GnRH-ant pretreatment may achieve similar efficacy to OCP pretreatment in patients with PCOS.[18] In conclusion, the characteristics of efficient inhibition and rapid and reversible action on the pituitary gland gave GnRH-ant special advantages as a simple and efficient pretreatment.